di Masi Alessandra, Sessa Rosario Luigi, Cerrato Ylenia, Pastore Gianni, Guantario Barbara, Ambra Roberto, Di Gioacchino Michael, Sodo Armida, Verri Martina, Crucitti Pierfilippo, Longo Filippo, Naciu Anda Mihaela, Palermo Andrea, Taffon Chiara, Acconcia Filippo, Bianchi Fabrizio, Ascenzi Paolo, Ricci Maria Antonietta, Crescenzi Anna
Department of Sciences, Roma Tre University, 00146 Rome, Italy.
CREA (Council for Agricultural Research and Economics), Research Centre for Food and Nutrition, 00178 Rome, Italy.
Antioxidants (Basel). 2022 Jul 27;11(8):1463. doi: 10.3390/antiox11081463.
Among the thyroid cancers, papillary thyroid cancer (PTC) accounts for 90% of the cases. In addition to the necessity to identify new targets for PTC treatment, early diagnosis and management are highly demanded. Previous data indicated that the multivariate statistical analysis of the Raman spectra allows the discrimination of healthy tissues from PTC ones; this is characterized by bands typical of carotenoids. Here, we dissected the molecular effects of carotenoid accumulation in PTC patients by analyzing whether they were required to provide increased retinoic acid (RA) synthesis and signaling and/or to sustain antioxidant functions. HPLC analysis revealed the lack of a significant difference in the overall content of carotenoids. For this reason, we wondered whether the carotenoid accumulation in PTC patients could be related to vitamin A derivative retinoic acid (RA) biosynthesis and, consequently, the RA-related pathway activation. The transcriptomic analysis performed using a dedicated PCR array revealed a significant downregulation of RA-related pathways in PTCs, suggesting that the carotenoid accumulation in PTC could be related to a lower metabolic conversion into RA compared to that of healthy tissues. In addition, the gene expression profile of 474 PTC cases previously published in the framework of the Cancer Genome Atlas (TGCA) project was examined by hierarchical clustering and heatmap analyses. This metanalysis study indicated that the RA-related pathways resulted in being significantly downregulated in PTCs and being associated with the follicular variant of PTC (FV-PTC). To assess whether the possible fate of the carotenoids accumulated in PTCs is associated with the oxidative stress response, the expression of enzymes involved in ROS scavenging was checked. An increased oxidative stress status and a reduced antioxidant defense response were observed in PTCs compared to matched healthy thyroids; this was possibly associated with the prooxidant effects of high levels of carotenoids. Finally, the DepMap datasets were used to profile the levels of 225 metabolites in 12 thyroid cancer cell lines. The results obtained suggested that the high carotenoid content in PTCs correlates with tryptophan metabolism. This pilot provided novel possible markers and possible therapeutic targets for PTC diagnosis and therapy. For the future, a larger study including a higher number of PTC patients will be necessary to further validate the molecular data reported here.
在甲状腺癌中,乳头状甲状腺癌(PTC)占病例的90%。除了需要确定PTC治疗的新靶点外,早期诊断和管理也备受需求。先前的数据表明,对拉曼光谱进行多变量统计分析可以区分健康组织和PTC组织;PTC组织的特征是具有类胡萝卜素典型的谱带。在这里,我们通过分析PTC患者体内类胡萝卜素积累是否需要增加视黄酸(RA)的合成和信号传导以及/或者维持抗氧化功能,来剖析其分子效应。高效液相色谱分析显示类胡萝卜素的总体含量没有显著差异。因此,我们想知道PTC患者体内类胡萝卜素的积累是否与维生素A衍生物视黄酸(RA)的生物合成有关,进而与RA相关途径的激活有关。使用专用PCR阵列进行的转录组分析显示PTC中RA相关途径显著下调,这表明与健康组织相比,PTC中类胡萝卜素的积累可能与较低的代谢转化为RA有关。此外,通过层次聚类和热图分析检查了先前在癌症基因组图谱(TGCA)项目框架内发表的474例PTC病例的基因表达谱。这项荟萃分析研究表明,RA相关途径在PTC中显著下调,并与PTC的滤泡变体(FV-PTC)相关。为了评估PTC中积累的类胡萝卜素的可能去向是否与氧化应激反应相关,检查了参与ROS清除的酶的表达。与匹配的健康甲状腺相比,PTC中观察到氧化应激状态增加和抗氧化防御反应降低;这可能与高水平类胡萝卜素的促氧化作用有关。最后,使用DepMap数据集分析了12种甲状腺癌细胞系中225种代谢物的水平。获得的结果表明,PTC中高类胡萝卜素含量与色氨酸代谢相关。这项初步研究为PTC的诊断和治疗提供了新的可能标志物和可能的治疗靶点。未来,需要进行一项更大规模的研究,纳入更多的PTC患者,以进一步验证此处报道的分子数据。